164 related articles for article (PubMed ID: 37218591)
21. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
[TBL] [Abstract][Full Text] [Related]
22. Effect of Lifestyle Coaching or Enhanced Pharmacotherapy on Blood Pressure Control Among Black Adults With Persistent Uncontrolled Hypertension: A Cluster Randomized Clinical Trial.
Nguyen-Huynh MN; Young JD; Ovbiagele B; Alexander JG; Alexeeff S; Lee C; Blick N; Caan BJ; Go AS; Sidney S
JAMA Netw Open; 2022 May; 5(5):e2212397. PubMed ID: 35583869
[TBL] [Abstract][Full Text] [Related]
23. Two self-management interventions to improve hypertension control: a randomized trial.
Bosworth HB; Olsen MK; Grubber JM; Neary AM; Orr MM; Powers BJ; Adams MB; Svetkey LP; Reed SD; Li Y; Dolor RJ; Oddone EZ
Ann Intern Med; 2009 Nov; 151(10):687-95. PubMed ID: 19920269
[TBL] [Abstract][Full Text] [Related]
24. Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).
Tsuyuki RT; Houle SK; Charrois TL; Kolber MR; Rosenthal MM; Lewanczuk R; Campbell NR; Cooney D; McAlister FA;
Circulation; 2015 Jul; 132(2):93-100. PubMed ID: 26063762
[TBL] [Abstract][Full Text] [Related]
25. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial.
Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ;
JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368
[TBL] [Abstract][Full Text] [Related]
26. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial.
Azizi M; Mahfoud F; Weber MA; Sharp ASP; Schmieder RE; Lurz P; Lobo MD; Fisher NDL; Daemen J; Bloch MJ; Basile J; Sanghvi K; Saxena M; Gosse P; Jenkins JS; Levy T; Persu A; Kably B; Claude L; Reeve-Stoffer H; McClure C; Kirtane AJ;
JAMA Cardiol; 2022 Dec; 7(12):1244-1252. PubMed ID: 36350593
[TBL] [Abstract][Full Text] [Related]
27. Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial.
Jafar TH; Jehan I; de Silva HA; Naheed A; Gandhi M; Assam P; Finkelstein EA; Quigley HL; Bilger M; Khan AH; Clemens JD; Ebrahim S; Turner EL; ; Kasturiratne A
Trials; 2017 Jun; 18(1):272. PubMed ID: 28606184
[TBL] [Abstract][Full Text] [Related]
28. Relationship of Blood Pressure, Health Behaviors, and New Diagnosis and Control of Hypertension in the BP-CHECK Study.
Hall YN; Anderson ML; McClure JB; Ehrlich K; Hansell LD; Hsu CW; Margolis KL; Munson SA; Thompson MJ; Green BB
Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e010119. PubMed ID: 38328915
[TBL] [Abstract][Full Text] [Related]
29. Effect and Acceptability of Mindfulness-Based Stress Reduction Program on Patients With Elevated Blood Pressure or Hypertension: A Meta-Analysis of Randomized Controlled Trials.
Lee EKP; Yeung NCY; Xu Z; Zhang D; Yu CP; Wong SYS
Hypertension; 2020 Dec; 76(6):1992-2001. PubMed ID: 33131316
[TBL] [Abstract][Full Text] [Related]
30. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
[TBL] [Abstract][Full Text] [Related]
31. Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension.
Ott C; Lobo MD; Sobotka PA; Mahfoud F; Stanton A; Cockcroft J; Sulke N; Dolan E; van der Giet M; Hoyer J; Furniss SS; Foran JP; Witkowski A; Januszewicz A; Schoors D; Tsioufis K; Rensing BJ; Saxena M; Scott B; Ng GA; Achenbach S; Schmieder RE
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 28003251
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of a WeChat-Based Multimodal Digital Transformation Management Model in New-Onset Mild to Moderate Hypertension: Randomized Clinical Trial.
Wang Y; Guo F; Wang J; Li Z; Tan W; Xie M; Yang X; Duan S; Song L; Cheng S; Liu Z; Liu H; Qiao J; Wang Y; Zhou L; Zhou X; Jiang H; Yu L
J Med Internet Res; 2023 Dec; 25():e52464. PubMed ID: 38048156
[TBL] [Abstract][Full Text] [Related]
33. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
34. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
[TBL] [Abstract][Full Text] [Related]
36. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial.
McManus RJ; Mant J; Haque MS; Bray EP; Bryan S; Greenfield SM; Jones MI; Jowett S; Little P; Penaloza C; Schwartz C; Shackleford H; Shovelton C; Varghese J; Williams B; Hobbs FD; Gooding T; Morrey I; Fisher C; Buckley D
JAMA; 2014 Aug; 312(8):799-808. PubMed ID: 25157723
[TBL] [Abstract][Full Text] [Related]
37. Superiority of Out-of-Office Blood Pressure for Predicting Hypertensive Heart Disease in Non-Hispanic Black Adults.
Rader F; Franklin SS; Mirocha J; Vongpatanasin W; Haley RW; Victor RG
Hypertension; 2019 Nov; 74(5):1192-1199. PubMed ID: 31522619
[TBL] [Abstract][Full Text] [Related]
38. Chronic Remote Ischemic Conditioning on Mild Hypertension in the Absence of Antihypertensive Medication: A Multicenter, Randomized, Double-Blind, Proof-of-Concept Clinical Trial.
Guo W; Zhao W; Li D; Jia H; Ren C; Li S; Zhao J; Yu B; Dong J; Guo R; Zhu K; Cao Y; Wang Y; Wang Y; Li Z; Wang Z; Wang D; Hou C; Hausenloy DJ; Chu X; Ji X
Hypertension; 2023 Jun; 80(6):1274-1282. PubMed ID: 37035920
[TBL] [Abstract][Full Text] [Related]
39. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial.
de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ;
Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial.
Green BB; Cook AJ; Ralston JD; Fishman PA; Catz SL; Carlson J; Carrell D; Tyll L; Larson EB; Thompson RS
JAMA; 2008 Jun; 299(24):2857-67. PubMed ID: 18577730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
